Health Warnings and Lawsuits Alleging Cancer Could Slow Januvia Use, DrugNews Reports

July 26, 2013

http://www.DrugNews.net is the web’s premier source for prescription drug warnings, research, side effects and legal news. Visit the DrugNews Center today.

Denver, CO (PRWEB) July 26, 2013

The diabetes drug safety center at DrugNews.net is announcing updated information for patients taking the medications Januvia or Janumet. Amid health warnings and growing patient lawsuits alleging cancer, financial analysts are anticipating use of the drugs could slow*.

DrugNews provides the latest warnings, recalls, studies and legal news to patients taking popular prescription drugs to improve consumer safety and awareness. Visitors can find out if others are experiencing similar side effects and decide if they need legal advice.

Januvia and Janumet are pill-form diabetes medications prescribed to help those with type-2 diabetes control blood sugar. The drugs were the best-selling brands for Merck last year, generating over $5.7 billion in revenue*.

DrugNews has added a 2011 study from UCLA, indicating drugs like Januvia could increase the rate of pancreatic cancer and thyroid cancer**. The Journal for the American Medical Association also warned this year that these drugs can double the risk of pancreatitis, a major risk factor for pancreatic cancer***.

After the American Diabetes Association called for new, independent testing of medications like Januvia, the British Medical Journal reported the drugs could be more dangerous than expected, and drug makers are withholding data that could allow new testing****.

Due to the number of patients filing a Januvia lawsuit alleging cancer, the Judicial Panel on Multidistrict Litigation met on July 25th to determine consolidation of cases to a special federal court*****. (In Re: Incretins Products Liability, Sales and Marketing Litigation, MDL 2452, United States Judicial Panel on Multidistrict Litigation).

Anyone affected by cancer after taking Januvia is encouraged to visit the DrugNews Center or speak with a lawyer about their legal options. However, due to the specialized nature of federal drug injury cases, DrugNews only recommends lawyers who have already handled Januvia lawsuits.

For more information on the research, side effects and litigation news related to Januvia and other drugs, or to speak with a lawyer, visit http://www.DrugNews.net.

*Forbes, 7/23/13; forbes.com/sites/ycharts/2013/07/23/mercks-5-7-billion-diabetes-franchise-vulnerable/

**Gastroenterology, July 2011; ctsi.ucla.edu/education/files/publicview/training/docs/FDA-analysis.pdf

***JAMA Internal Medicine, 2/25/13; archinte.jamanetwork.com/article.aspx?articleid=1656537

****MedPage Today, 6/12/13; medpagetoday.com/Endocrinology/Diabetes/39803

*****JPML, 6/12/13; jpml.uscourts.gov/sites/jpml/files/Hearing_Order-7-25-13.pdf

For the original version on PRWeb visit: http://www.prweb.com/releases/januvia-cancer/lawsuit-settlement/prweb10965922.htm

Source: prweb

comments powered by Disqus